[Initial clinical experience in treating primary liver cancer with immunostimulating agents used systemically or within the tumor].
D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000008:administration & dosage; D005260:Female; D006498:Hepatectomy; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D007167:Immunotherapy; D008026:Ligation; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011278:Pregnanes / Q000008:administration & dosage*
D001500:BCG Vaccine; D004983:Ethanolamines; D011278:Pregnanes
Pervyĭ klinicheskiĭ opyt lecheniia pervichnogo raka pecheni immunostimuliruiushchimi veshchestvami, primeniaemymi sistemnym ili vnutriopukholevym putem